10 studies found for:    Lersivirine
Show Display Options
Rank Status Study
1 Completed The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Lersivirine;   Drug: Placebo;   Drug: Lersivirine (if necessary);   Drug: Moxifloxacin
2 Completed Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects
Condition: Healthy Volunteer
Interventions: Drug: Lersivirine Immediate-Release (fasted);   Drug: Lersivirine Modified-Release #1 (fasted);   Drug: Lersivirine Modified-Release #2 (fasted);   Drug: Lersivirine Modified-Release #3 (fasted);   Drug: Lersivirine Modified-Release (fed)
3 Completed Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
4 Completed Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
5 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
6 Completed Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)
Condition: Healthy Volunteers
Interventions: Drug: Lersivirine;   Drug: Rifabutin
7 Terminated
Has Results
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
Condition: HIV-1
Interventions: Drug: lersivirine;   Drug: efavirenz;   Drug: etravirine
8 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone
Condition: Healthy Volunteers
Interventions: Drug: Methadone;   Drug: Lersivirine + Methadone
9 Completed
Has Results
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Condition: HIV-1
Interventions: Drug: UK-453, 061;   Drug: EFV +TVA
10 Terminated
Has Results
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
Interventions: Drug: UK-453,061 Dose 1;   Drug: UK-453,061 Dose 2;   Drug: Etravirine

Indicates status has not been verified in more than two years